Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2025
Reporting Period: Fiscal quarter ended March 31, 2025
This filing serves as a notification that the company issued a press release on May 7, 2025, announcing operating results for the first quarter of fiscal year 2025 and providing financial guidance for the full fiscal year ending June 30, 2025.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The filing states that detailed results are contained in the attached press release (Exhibit 99.1). Consequently, the following metrics are not available in this document:
- Revenue
- Profit (Net Income/EBITDA)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It only confirms that a press release was issued to announce the results for the quarter ended March 31, 2025.
Guidance, Outlook, and Management Commentary
Guidance: The company issued financial guidance for the fiscal year ending June 30, 2025, as referenced in the press release attached as Exhibit 99.1.
Management Commentary: No specific commentary is included in the 8-K text itself; all operational details and outlook are deferred to the press release.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 7, 2025) for actual revenue, earnings, and margin figures.
- Verify the specific full-year 2025 financial guidance numbers provided in the press release.
- Compare the Q1 2025 results against Q1 2024 to assess year-over-year growth trends.
- Check for any updates on liquidity or debt covenants mentioned in the full press release.